NeoGenomics, Inc. Debt and Lease Obligation
NeoGenomics, Inc. (NEO) had Debt and Lease Obligation of $538.20 million as of 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:DebtAndCapitalLeaseObligations · last filed 2024-02-20
- 2023-12-31: Debt and Lease Obligation $538.20M.
- 2022-12-31: Debt and Lease Obligation $535.39M.
- 2021-12-31: Debt and Lease Obligation $533.69M.
- 2021-09-30: Debt and Lease Obligation $533.50M.
| Period end | Debt and Lease Obligation | Debt and Lease Obligation as first filed |
|---|---|---|
| 2023-12-31 | $538.20M 10-K · filed 2024-02-20 | |
| 2022-12-31 | $535.39M 10-K · filed 2024-02-20 | |
| 2021-12-31 | $533.69M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $533.50M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $533.44M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $533.15M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $171.93M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $171.54M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $170.91M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $103.62M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $105.46M 10-K · filed 2021-02-25 | $106.13M 10-K · filed 2020-02-28 |
| 2019-09-30 | $109.73M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $110.61M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $111.54M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $113.30M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $111.40M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $140.64M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $102.82M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $107.19M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $106.94M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $111.30M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $113.07M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $108.37M 10-K · filed 2018-03-13 | |
| 2015-12-31 | $64.73M 10-K · filed 2017-03-14 | $64.73M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |